Mixed community-acquired pneumonia in hospitalised patients

被引:66
|
作者
de Roux, A
Ewig, S
García, E
Marcos, MA
Mensa, J
Lode, H
Torres, A
机构
[1] Hosp Clin Barcelona, Dept Pulm, Serv Malad Infect, E-08036 Barcelona, Spain
[2] Hosp Clin Barcelona, Dept Pulm, Microbiol Serv, E-08036 Barcelona, Spain
[3] Univ Barcelona, Fac Med, Serv Pneumol Allergia Resp, Inst Clin Torax,Inst Invest Biomed August Pi Suny, Barcelona 7, Spain
[4] Augusta Kranken Anstalt Bochum, Klin Pneumol, Bochum, Germany
[5] Abt Pneumol, Lungenklin Heckenshorn, Berlin, Germany
关键词
community-acquired pneumonia; hospitalisation; mixed pneumonia;
D O I
10.1183/09031936.06.00058605
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The role of mixed community-acquired pneumonia (CAP) is controversial. The aim of the present study was to determine the incidence, principal microbial patterns, clinical predictors and course of mixed CAP. The current study included 1,511 consecutive hospitalised patients with CAP. Of these, 610 (40%) patients had an established aetiology. One pathogen was demonstrated in 528 patients and 82 (13%) patients had mixed pneumonia. Cases including CAP, by a pyogenic bacteria and a complete paired serology for "atypicals", revealed that 82 (13%) patients had definite single pyogenic pneumonia and 28 patients (5%) had mixed pyogenic pneumonia. In patients with mixed CAP, Streptococcus pneumoniae was the most prevalent microorganism (44 out of 82; 54%). The most frequent combination was S. pneurnoniae with Haemophilus influenzae (17 out of 82; 21%). Influenza virus A and S. pneumoniae (five out of 28; 18%) was the most frequent association in the mixed pyogenic pneumonia group. No clinical predictors for mixed pneumonias could be identified. Patients with mixed pyogenic pneumonia more frequently developed shock when compared with patients with single pyogenic pneumonia (18 versus 4%). In conclusion, mixed pneumonia occurs in > 10% of cases with community-acquired pneumonia requiring hospitalisation.
引用
收藏
页码:795 / 800
页数:6
相关论文
共 50 条
  • [21] Community-acquired pneumonia
    Remington, Leah T.
    Sligl, Wendy I.
    CURRENT OPINION IN PULMONARY MEDICINE, 2014, 20 (03) : 215 - 224
  • [22] Community-acquired pneumonia
    Carbonara, Sergio
    Monno, Laura
    Longo, Benedetta
    Angarano, Gioacchino
    CURRENT OPINION IN PULMONARY MEDICINE, 2009, 15 (03) : 261 - 273
  • [23] Community-acquired pneumonia
    Martin, Simon W.
    Al-Haddad, Mohammed
    ANAESTHESIA AND INTENSIVE CARE MEDICINE, 2010, 11 (11) : 478 - 480
  • [24] Community-acquired pneumonia
    Falguera, M.
    Ramirez, M. F.
    REVISTA CLINICA ESPANOLA, 2015, 215 (08): : 458 - 467
  • [25] Community-acquired pneumonia
    Seeger, Alexander
    Rohde, Gernot
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2023, 148 (06) : 335 - 341
  • [26] Community-acquired pneumonia
    Allan, Russell
    Martin, Simon W.
    Al-Haddad, Mohammed
    ANAESTHESIA AND INTENSIVE CARE MEDICINE, 2016, 17 (10) : 510 - 513
  • [27] Adrenal function in patients with community-acquired pneumonia
    Gotoh, S.
    Nishimura, N.
    Takahashi, O.
    Shiratsukar, H.
    Horinouchi, H.
    Ono, H.
    Uchiyama, N.
    Chohnabayashi, N.
    EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (06) : 1268 - 1273
  • [28] Assessing Severity of Patients with Community-Acquired Pneumonia
    Pereira, Jose Manuel
    Paiva, Jose Artur
    Rello, Jordi
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 33 (03) : 272 - 283
  • [29] EFFICACY OF IMMUNOVENIN IN PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA
    Farkhutdinov, U. R.
    Mirkhaidarov, A. M.
    Farkhutdinov, R. R.
    Farkhutdinov, Sh. U.
    TERAPEVTICHESKII ARKHIV, 2011, 83 (03) : 40 - 44
  • [30] Community-acquired Pneumonia and Hospital-acquired Pneumonia
    Lanks, Charles W.
    Musani, Ali, I
    Hsia, David W.
    MEDICAL CLINICS OF NORTH AMERICA, 2019, 103 (03) : 487 - +